[1]
Shrivastava, N. and Rani, R. 2023. Efficacy and safety of ormeloxifene, a selective estrogen receptor modulator in management of dysfunctional uterine bleeding in perimenopausal patients: a prospective interventional study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 12, 12 (Nov. 2023), 3474–3478. DOI:https://doi.org/10.18203/2320-1770.ijrcog20233620.